LENSAR, Inc.
NASDAQ:LNSR
5.06 (USD) • At close September 13, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | LENSAR, Inc. |
Symbool | LNSR |
Munteenheid | USD |
Prijs | 5.06 |
Beurswaarde | 58,738,504 |
Dividendpercentage | 0% |
52-weken bereik | 1.8 - 5.6 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Nicholas T. Curtis |
Website | https://www.lensar.com |
An error occurred while fetching data.
Over LENSAR, Inc.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)